82
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Increased Risk of Glaucoma in Patients with Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study

, , , &
Pages 134-144 | Received 30 Jul 2022, Accepted 09 May 2023, Published online: 14 May 2023
 

ABSTRACT

Purpose

The risk of glaucoma in patients suffering from Sjögren’s syndrome has not been elucidated. We aimed for evaluating the absolute incidence as well as the relative risk of glaucoma in patients with SS at the level of the whole country population.

Methods

We conducted a retrospective cohort study using a national health insurance database in Taiwan from 2000 to 2013. We used International Classification of Diseases, Ninth Revision, to categorise medical conditions for study group and comparison group. We used Cox proportional hazard regression analysis to determine adjusted hazard ratios (aHRs) of glaucoma between study and comparison group after adjusting for sex, age, and comorbidities.

Results

Among 17,398 patients with primary Sjögren’s syndrome, 133 patients were diagnosis with glaucoma during follow-up. Of the 69,592 non-primary Sjögren’s syndrome patients, 429 patients developed glaucoma. Glaucoma risk was elevated in patients with primary Sjögren’s syndrome than in the non-Sjögren’s syndrome group (adjusted hazard ratio [HR] 2.274, 95% in the confidence interval [95% CI] 1.847–2.800; P < .001).

Conclusions

The risk of glaucoma among the population having Sjögren’s syndrome was higher than those did not have Sjögren’s syndrome. It indicated the necessity of regular examination for glaucoma in patients with Sjögren’s syndrome.

Disclosure statement

No potential conflict of interest was reported by the authors.

SUPPLEMENTARY MATERIAL

Supplemental data for this article can be accessed online at https://doi.org/10.1080/09286586.2023.2213766

Additional information

Funding

The study was funded by the National Defense Medical Center and Tri Service General Hospital (TSGH-B-111018, TSGH-B-112020). The sponsors have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.